ABC Heart Fail Cardiomyop 2023; 3(1): e20230028
Endomyocardial Fibrosis: Viewpoint
Luma Ornelas Sousa Rêgo, Gustavo Sampaio Vilas-Boas
, André Rodrigues Durães
Abstract
Endomyocardial fibrosis (EMF) is a restrictive cardiomyopathy of unknown origin, affecting mainly young people from tropical countries. EMF is considered to be the most restrictive cardiomyopathy in the world. The main risk factors for EMF appear to be age, gender, ethnicity, social vulnerability, and eosinophilia. The deposition of fibrotic tissue in the endocardium, myocardium, and heart valves leads to a decrease in the ventricular cavity and dysfunction in the diastolic filling of the ventricles. In this article we will express our point of view on this pathology, which is relatively unknown and with limited treatment options.
Keywords: Cardiomyopathy; Endomyocardial; Fibrosis; Ventricles
750
